2025 TSNO&TSBS Call for papers
Dear Esteemed Members and Colleagues,
The Taiwan Society for Neuro-Oncology(TSNO) and the Taiwan Society for Skull Base Surgery(TSBS) cordially invite you to attend the 12th First Annual Meeting of TSNO and 12th Second Annual Meeting of TSBS, jointly held with the annual Academic symposium on September 20, 2025, at the International Conference Hall of Linkou Chang Gung Memorial Hospital (near to the Taoyuan Transfer Station)
This year’s conference will gather leading national experts and scholars in skull base surgery and neuro-oncology to share the latest clinical treatments and create a platform for interdisciplinary collaboration. We aim to promote both clinical practice and basic research. We sincerely invite all professionals and colleagues to actively submit abstracts and share your latest research findings.
Important Dates:
1.Abstract Submission Deadline:
⛔ July 31, 2025
2.Submission Method:
⛔ Online Submission form
3.Notification of Abstract Acceptence:
⛔ August 15, 2025
4.Deadline for E-poster Submission:
⛔ September 5, 2025
5.Submission Guideline:
◉ All abstract must be submitted through the officail TSNO 2025 submission wedsite: http://www.tsno.org.tw/
◉ Encore abstracts (previously presented at other conference or published in journal) are permitted but must include details of the prior presentation or publication.
◉ There is no limit on the number of abstracts that can be submitted per account.
◉ The same abstract cannot be submitted under different abstract categories.
◉ All correspondence will be sent to the person submitting the abstract (presenting author).
6. Abstract Requirements:
(1) Abstract Authors:
◉ The submitter is considered the first author, presenting author, and corresponding author by default.
◉ Full registration payment is required for presenting authors to be entitled to present.
◉ The number of co-authors is limited to a maximum of 10.
(2) Abstract Title:
◉ The title must not exceed 50 words, excluding spaces.
◉ Author and institution information must not appear in the title. If either an author's name or institution information appears, the abstract will be disqualified. (3) Presentation Type:
(3) Abstract Type:
◉ Submitters may choose their preferred presentation type (Oral or E-Poster). However, the TSNO 2025 Scientific Committee will make the final decision after review.
(4) Research Type:
There are two research types:
◉ Basic Research: The abstract body must include: Objectives, Materials & Methods, Results, and Conclusion.
◉ Case Reports: The abstract body must include: Introduction, Case Description, and Discussion/Conclusion.
(5) Abstract Body/Text:
◉ The abstract body must not exceed 400 words, excluding spaces.
◉ Images and tables must not be pasted in the abstract text. Each abstract may include ONE image (JPG or PNG format, max. 5MB), which should be uploaded separately into the submission system. This image can be a figure or a table.
7. Presentation Formats:
?Oral Posters:
◉ Selected abstracts will be invited for oral presentation during the conference. Presenters must also submit an e-poster.
?E-Poster Presentations:
◉ Accepted abstracts will be displayed as e-posters on the official TSNO 2025 website.
?E-Poster Format & Deadline:
◉ Required for all accepted abstracts (including oral presentations)
◉ Format: Use the official TSNO 2025 E-Poster Template (available on the website after August 15, 2025)
◉ Export as PDF for upload
◉ Deadline: September 5, 2025, 23:59 (Taiwan Time)
◉ Note: Printed posters are not accepted
8. Additional Notes:
◉ Ethical Considerations: Authors must ensure compliance with ethical standards, including obtaining approval from relevant institutional review boards for studies involving human subjects.
◉ Conflict of Interest: All potential conflicts must be disclosed in the submission form.
◉ Plagiarism: TSNO 2025 has a strict policy against plagiarism. Submissions found to violate this policy will be rejected.
9. Abstract Categories (13 total):
(1).Basic Science-Neuro-oncology, Molecular Biology, Genetic
(2).Neurosurgical Techniques
(3).Pediatric Brain Tumors
(4).Radiation Oncology
(5).Medical Oncology and Chemotherapy
(6).Supportive Care and Palliative Medicine
(7).Neuropathology
(8).Supportive and Palliative Care
(9).Immunotherapy and Targeted Therapies
(10).Clinical Trials and Translational Research
(11).Recurrent Tumor Management
(12).Skull Base Surgery
(13).Other
Submission LINK : https://reurl.cc/EVAxkA